Charles Schwab’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.01M | Sell |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $1.59M | Buy |
|
|||||
|
2021
Q3 | $3.22M | Sell |
|
|||||
|
2021
Q2 | $5.29M | Buy |
|
|||||
|
2021
Q1 | $5.46M | Buy |
|
|||||
|
2020
Q4 | $6.6M | Buy |
|
|||||
|
2020
Q3 | $7.21M | Buy |
|
|||||
|
2020
Q2 | $8.7M | Buy |
|
|||||
|
2020
Q1 | $7.45M | Buy |
|
|||||
|
2019
Q4 | $11.5M | Buy |
|
|||||
|
2019
Q3 | $4.77M | Buy |
|
|||||
|
2019
Q2 | $5.76M | Buy |
|
|||||
|
2019
Q1 | $4.74M | Buy |
|
|||||
|
2018
Q4 | $2.04M | Buy |
|
|||||
|
2018
Q3 | $2.92M | Sell |
|
|||||
|
2018
Q2 | $3.74M | Buy |
|
|||||
|
2018
Q1 | $4.69M | Buy |
|
|||||
|
2017
Q4 | $3.08M | Buy |
|
|||||
|
2017
Q3 | $4.14M | Buy |
|
|||||
|
2017
Q2 | $2.3M | Sell |
|
|||||
|
2017
Q1 | $2.77M | Buy |
|
|||||
|
2016
Q4 | $1.56M | Buy |
|
|||||
|
2016
Q3 | $1.21M | Sell |
|
|||||
|
2016
Q2 | $1.3M | Buy |
|
|||||
|
2016
Q1 | $1.52M | Buy |
|
|||||
|
2015
Q4 | $1.28M | Buy |
|
|||||
|
2015
Q3 | $999K | Buy |
|
|||||
|
2015
Q2 | $1.76M | Buy |
|
|||||
|
2015
Q1 | $723K | Buy |
|
|||||
|
2014
Q4 | $690K | Buy |
|
|||||
|
2014
Q3 | $765K | Buy |
|
|||||
|
2014
Q2 | $861K | Buy |
|
|||||
|
2014
Q1 | $397K | Buy |
|
|||||
|
2013
Q4 | $267K | Buy |
|
|||||
|
2013
Q3 | $511K | Buy |
|
|||||
|
2013
Q2 | $354K | Buy |
|